257 Combination of adenosine antagonists A2AR (TT-10) and A2BR (TT-4) with checkpoint inhibitors demonstrate anti-tumor activity in CT-26 murine colon tumor allograft model

• Brian Schwartz,
• Desa Rae Pastore,
• Sushant Kumar,
• Kasim Mookhtiar,
• Vijay Reddy

Affiliations

Brian Schwartz

Sunnybrook Osler Centre for Prehospital Care, Toronto, Ontario, Canada

Desa Rae Pastore

Tarus Therapeutics, Batavia, NY, USA

Sushant Kumar

Tarus Therapeutics, Batavia, NY, USA

Kasim Mookhtiar

Tarus Therapeutics, Batavia, NY, USA

Vijay Reddy

Tarus Therapeutics, Batavia, NY, USA